News

GlycosBio has created a platform that can consume carbon from multiple non-sugar feedstock sources to produce a variety of chemical products. The approach not only eliminates the risk

GeNO said that the initial indication to be studied for nitric oxide delivered via the GeNO Nitrosyl delivery system is as a diagnostic agent for administration as an

The company is the maker of Vagisil brand feminine hygiene products and had been marketing Vagisil deodorant powder in a 7-oz bottle size. The company intended to come

Orphan-drug designation will be granted by the FDA Office of Orphan Drug Products Development to novel drugs or biologics that may treat a condition affecting less than 200,000

According to the agreement, Omeros is responsible for clinical and commercial milestone payments to Asubio. Omeros would also pay a single-digit royalty to Asubio upon potential sale of

Ms Hancook, most recently a short-term consultant and contractor, will join Viachem from Intervoice/Convergys where she was director of worldwide corporate communications. She has also headed marketing, business

Takeda Pharma North America will start marketing the drug under the new name in late April 2010. After Kapidex was approved in January 2009, there have been reports

Through a separate process, the EU Committee for Orphan Medicinal Products (COMP) concurrently also granted IMGN901 orphan medicinal product designation for the treatment of MCC. IMGN901 is an

Pharmadule’s scope comprises design, fabrication, installation and validation of a complete biotech production facility. Pharmadule said that its modular concept allows 80% of the construction to be completed